| PERIOD ENDING | 31-Oct-09 | 30-Apr-09 | 31-Jan-09 | 31-Oct-08 | | Total Revenue | 80,764 | 875,060 | 388,796 | 152,781 | | Cost of Revenue | 124,268 | 630,006 | 254,393 | 177,498 | | | Gross Profit | (43,504) | 245,054 | 134,403 | (24,717) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative |
-
|
-
|
-
|
-
| | Non Recurring |
-
| 808 | 422 | 180 | | Others | 27,184 | 80,098 | 27,438 | 25,078 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (64,714) | 164,148 | 106,543 | (49,975) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 6,204 | 3,194 | 1,497 | 1,658 | | Earnings Before Interest And Taxes | (64,230) | 163,152 | 104,252 | (45,966) | | Interest Expense | 4,835 | 21,732 | 7,295 | 7,947 | | Income Before Tax | (69,065) | 141,420 | 96,957 | (53,913) | | Income Tax Expense | (25,554) | 53,740 | 36,412 | (19,409) | | Minority Interest | 2,338 | (4,190) | (3,788) | 2,351 | | | | Net Income From Continuing Ops | (40,919) | 87,680 | 60,545 | (34,504) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (41,173) | 87,680 | 60,545 | (34,504) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($41,173) | $87,680 | $60,545 | ($34,504) |
|
0.02% Nasdaq 0.00%
Income Statement
